Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with androgenic alopecia may have a higher risk of artery problems.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

COVID-19 may cause temporary hair loss in some people.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Metformin is less effective in men with early-onset hair loss.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Combining two treatments for hair loss works better than using just one.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Natural and holistic treatments offer alternative options for nail psoriasis and hair loss.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Hair loss significantly affects emotional and social well-being.

Hair loss significantly affects emotional and social well-being.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Hair loss can affect mood, self-esteem, body image, and quality of life.

Nutritional supplements with natural DHT inhibitors are effective for treating androgenetic alopecia.

Major depression disorder increases the risk of alopecia areata, and vice versa.

The combination of microneedling, PRP, and minoxidil is more effective for hair loss than minoxidil alone.

Personalized treatment plans are crucial for effectively managing male pattern baldness.

Stigmatization and quality of life in people with alopecia are influenced by gender and sociodemographics, suggesting a need for better support.

New methods reliably assess hair regrowth and scalp health in hair loss patients.